|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
Im Neuenheimer Feld 582, Heidelberg, BW 69120, DE
|
|
Affimed N.V. (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The company’s proprietary ROCK® platform predictably generates customized innate cell engagers (ICE®), bispecific antibodies, which target innate immune cells to destroy tumor cells.
The broad pipeline enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors. It comprises wholly owned and partnered programs and builds on monotherapy or combination approaches with Natural Killer (NK) cell products or other I-O therapeutics.
The lead candidate AFM13 is in development for patients with CD30+ lymphomas and has broad clinical development potential as monotherapy and in combination with NK cells and other I-O therapies, such as PD-1 inhibitors.
AFM24 is specific for EGFR and CD16A and targets solid tumors. Three Phase 1 studies, with AFM24 as monotherapy or in combination with NK cells or anti-PD-L1 are ongoing.
AFM28 targets CD123 and CD16A and is in development for patients relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) as mono- or combination therapy.
|
Affimed Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}.{last} | [email protected] |
66.67%
|
The widely used Affimed email format is {f}.{last} (e.g. [email protected]) with 66.67% adoption across the company.
To contact Affimed customer service number in your country click here to find.
Adi Hoess is the CEO of Affimed. To contact Adi Hoess email at [email protected] or [email protected]. Or you may call 19162052868
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.